Clinical Trials

34 enrolled

Hematologic Neoplasms

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Classical hematologyLymphoidOther hematologic neoplasm

28 enrolled

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07123662 2025-08-14

γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Phase EARLY_PHASE1 Not yet recruiting

8 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Leukemia

NCT06702098 2024-11-22

iNK-r/r AML

10 enrolled

Leukemia, Myeloid, Acute

NCT03537482 2024-08-19

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

90 enrolled

Hematologic Neoplasms

NCT06541405 2024-08-07

Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia

9 enrolled

Leukemia, Myeloid, Acute

NCT06541444 2024-08-07

Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia

9 enrolled

Leukemia, Myeloid, Acute

NCT05707325 2024-07-24

Reboot-101

30 enrolled

Phase EARLY_PHASE1 Terminated

Neoplasms, Hematologic Neoplasms

NCT03224819 2023-09-01

Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)

46 enrolled 40 charts

Leukemia, Myeloid, Acute

NCT05722171 2023-02-10

Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

10 enrolled

Leukemia, Myeloid, Acute

NCT05480501 2022-07-29

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

9 enrolled

Burkitt Lymphoma, Leukemia

NCT05432401 2022-06-27

TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia

18 enrolled

Leukemia, Myeloid, Acute

NCT04700319 2021-03-08

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

30 enrolled

Hematologic Neoplasms

NCT04439721 2021-01-06

γδT

5 enrolled

Leukemia, Leukemia, B-Cell

NCT04626765 2020-11-13

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04209712 2020-07-29

Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease

6 enrolled

Leukemia, Myeloid, Acute

NCT04156243 2019-11-12

CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies

20 enrolled

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03910842 2019-09-06

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

12 enrolled